Stockscreener 앱 받기
15.80
4.53%
-0.75
시장 영업 전:
15.41
-0.39
-2.47%
전일 마감가:
$16.55
열려 있는:
$16.5
하루 거래량:
680.99K
Relative Volume:
0.60
시가총액:
$1.13B
수익:
$133.62M
순이익/손실:
$-177.37M
주가수익비율:
-5.4671
EPS:
-2.89
순현금흐름:
$23.50M
1주 성능:
-7.93%
1개월 성능:
+1.15%
6개월 성능:
+90.13%
1년 성능:
-36.90%
1일 변동 폭
$15.62
$16.89
1주일 범위
$15.62
$17.62
52주 변동 폭
$6.92
$25.52
Xencor Inc Stock (XNCR) Company Profile
명칭
Xencor Inc
전화
626-305-5900
주소
465 N. HALSTEAD ST., PASADENA, CA
XNCR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
15.80 | 1.18B | 133.62M | -177.37M | 23.50M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.52 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.79 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
862.05 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.10 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.46 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-24 | 개시 | Truist | Buy |
| 2025-10-29 | 업그레이드 | Barclays | Underweight → Overweight |
| 2025-09-17 | 재개 | Barclays | Underweight |
| 2025-09-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-04-21 | 개시 | William Blair | Outperform |
| 2024-12-12 | 개시 | Wells Fargo | Overweight |
| 2024-12-02 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-04-16 | 재확인 | BTIG Research | Buy |
| 2024-02-28 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-05-19 | 개시 | BofA Securities | Buy |
| 2022-12-06 | 개시 | Cowen | Outperform |
| 2022-10-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2022-09-21 | 개시 | JP Morgan | Overweight |
| 2022-07-06 | 재개 | Canaccord Genuity | Buy |
| 2022-02-11 | 개시 | BMO Capital Markets | Outperform |
| 2022-01-21 | 개시 | SMBC Nikko | Outperform |
| 2021-12-15 | 개시 | H.C. Wainwright | Buy |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-02-24 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-03-04 | 개시 | Barclays | Underweight |
| 2020-02-25 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-01-30 | 개시 | RBC Capital Mkts | Outperform |
| 2019-11-20 | 재개 | Guggenheim | Neutral |
| 2019-08-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-08-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-06-13 | 개시 | Mizuho | Buy |
| 2019-04-12 | 개시 | Guggenheim | Buy |
| 2019-03-27 | 개시 | Berenberg | Buy |
| 2019-03-15 | 개시 | Raymond James | Outperform |
| 2018-09-10 | 재개 | BTIG Research | Buy |
| 2018-03-28 | 재개 | Leerink Partners | Outperform |
| 2017-03-02 | 개시 | Instinet | Neutral |
| 2017-03-02 | 재확인 | Wedbush | Outperform |
| 2016-10-04 | 개시 | Piper Jaffray | Overweight |
| 2015-12-22 | 개시 | Canaccord Genuity | Buy |
| 2015-08-05 | 재확인 | MLV & Co | Buy |
| 2015-02-12 | 재확인 | Oppenheimer | Outperform |
| 2015-01-28 | 재확인 | MLV & Co | Buy |
| 2014-07-11 | 개시 | Oppenheimer | Outperform |
모두보기
Xencor Inc 주식(XNCR)의 최신 뉴스
Incyte wins EU approval of Xencor-partnered lymphoma drug - Seeking Alpha
Xencor’s New Study on XmAb657: A Potential Game-Changer for Muscle Diseases - TipRanks
Fundamentals Check: Why Xencor Inc XE9 stock signals breakout potential - moha.gov.vn
Free cash flow per share of Xencor, Inc. – GETTEX:XE9 - TradingView — Track All Markets
Xencor issued US patent for Xtend FC domain - MSN
Xencor Announces Extension of U.S. Patent Term on Certain Xtend™ Antibodies - BioSpace
Xencor (XNCR) Is Up 7.1% After Ultomiris Royalty Patent ExtensionWhat's Changed - simplywall.st
248,706 Shares in Xencor, Inc. $XNCR Acquired by Walleye Capital LLC - MarketBeat
Xencor Granted US Patent Extension of Certain Xtend Antibodies, Expects Additional Royalty Revenue - marketscreener.com
Xencor issued U.S. patent for Xtend Fc domain - TipRanks
Xencor extends Ultomiris royalty term to 2028 with new patent - Investing.com
Xencor extends Ultomiris royalty term to 2028 with new patent By Investing.com - Investing.com South Africa
Xencor Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Pullback Watch: What momentum indicators show for Xencor Inc stock2025 Sector Review & Smart Swing Trading Alerts - moha.gov.vn
Is Xencor Stock Built to Withstand a Pullback? - Trefis
How Xencor Inc. stock performs in interest rate cycles2025 Geopolitical Influence & Detailed Earnings Play Alerts - Newser
Xencor, Inc. $XNCR Shares Acquired by Panagora Asset Management Inc. - MarketBeat
What hedge fund moves indicate for Xencor Inc. (XE9) stockWeekly Earnings Recap & Low Drawdown Investment Strategies - Newser
What momentum indicators show for Xencor Inc. stock2025 Price Action Summary & High Conviction Investment Ideas - Newser
Its Stock Has Paid Off Big Time For Xencor Inc - setenews.com
Is Xencor Inc. stock a defensive play in 2025Quarterly Profit Review & Daily Growth Stock Investment Tips - Newser
Xencor (XNCR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Xencor Inc. diskutieren - sharewise.com
How supply shortages influence Xencor Inc. (XE9) stockJuly 2025 Opening Moves & Safe Capital Investment Plans - BỘ NỘI VỤ
Xencor, Inc. (XNCR) Stock Forecasts - Yahoo Finance
Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Rhenman & Partners Asset Management AB Has $1.30 Million Stake in Xencor, Inc. $XNCR - MarketBeat
Will Xencor Inc. (XE9) stock remain on Wall Street radarJuly 2025 Sector Moves & Real-Time Volume Triggers - BỘ NỘI VỤ
Truist Financial Initiates a Buy Rating on Xencor (XNCR) - The Globe and Mail
Xencor (NASDAQ:XNCR) Coverage Initiated by Analysts at Truist Financial - MarketBeat
There's No Escaping Xencor, Inc.'s (NASDAQ:XNCR) Muted Revenues Despite A 27% Share Price Rise - simplywall.st
DCF Advisers LLC Cuts Stake in Xencor, Inc. $XNCR - MarketBeat
Xencor Shares Surge on Clinical Breakthroughs and Analyst Confidence - Ad-hoc-news.de
Truist Securities Initiates Coverage of Xencor (XNCR) with Buy Recommendation - MSN
Truist Securities initiates coverage on Xencor stock with Buy rating By Investing.com - Investing.com Canada
Truist Securities Initiates Coverage on Xencor (XNCR) with Buy R - GuruFocus
Truist Securities initiates coverage on Xencor stock with Buy rating - Investing.com India
Xencor’s XmAb819 Study: A Promising Step in Cancer Treatment - MSN
Primecap Management Co. CA Has $82.75 Million Holdings in Xencor, Inc. $XNCR - MarketBeat
Is Xencor Inc. stock a safe buy before earningsJuly 2025 Reactions & Free High Accuracy Swing Entry Alerts - newser.com
Will Xencor Inc. (XE9) stock benefit from commodity supercycleJuly 2025 Outlook & Weekly Setup with High ROI Potential - newser.com
Xencor Shares Show Renewed Promise as Biotech Specialist Stages Recovery - Ad-hoc-news.de
Bank of Montreal Can Boosts Holdings in Xencor, Inc. $XNCR - MarketBeat
Xencor Inc (XE9.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is Xencor Inc. (XE9) stock undervalued by metricsWeekly Loss Report & Free Long-Term Investment Growth Plans - newser.com
Xencor upgraded to Overweight from Underweight at Barclays - MSN
Will Xencor Inc. (XE9) stock hit Wall Street targetsWatch List & Long Hold Capital Preservation Plans - newser.com
Xencor Inc (XNCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.18%
0.62%
자본화:
|
볼륨(24시간):